Immunogenicity of HIV Type 1 gp120 CD4 Binding Site Phage Mimotopes
- 1 January 2005
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 21 (1) , 82-92
Abstract
The conserved domain of the CD4 binding site (CD4bs) on the human immunodeficiency virus type 1 (HIV- 1) envelope represents a potential target for vaccine development. Here we describe selection of peptide mimotopes by panning a phage peptide library on the HIV-1 CD4bs-specific, broadly neutralizing anti-HIV-1 monoclonal antibody, IgG1 b12. We identified an initial consensus sequence for IgG1 b12 binding (M/VΘSD, where Θ represents an aromatic amino acid). A molecular evolution approach, using second- and third-generation libraries, led us to identify a refined consensus sequence (GLLVWSDEL). The resulting IgG1 b12 phage mimotopes compete with gp160 for the IgG1 b12 antigen-binding site, but the phage coat protein (pIII) may play an important structural role, since both free peptides and KLH-conjugated peptides have no detectable binding activity. Mice immunized with IgG1 b12 phage mimotopes elicited a weak but persistent humoral response directed against the HIV-1 envelope. An antibody fragment was isolated from the antibody repertoires of these animals. It is noteworthy that while it has a relatively low affinity for HIV-1 gp160, the antibody targets an epitope that overlaps with that of IgG1 b12. Our data therefore suggest that engineered IgG1 b12 mimotopes share immunogenic features with the CD4bs. However, these peptidic structures will require further improvement in order to generate broad specificity neutralizing antibodies like IgG1 b12.Keywords
This publication has 56 references indexed in Scilit:
- HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sitesNature, 2002
- Identification and Characterization of a Peptide That Specifically Binds the Human, Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody b12Journal of Virology, 2001
- Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120European Journal of Immunology, 1998
- NMR structure of the principal neutralizing determinant of HIV-1 displayed in filamentous bacteriophage coat proteinJournal of Molecular Biology, 1997
- Antibody neutralization of HIV-1Immunology Today, 1996
- Molecular Profile of an Antibody Response to HIV-1 as Probed by Combinatorial LibrariesJournal of Molecular Biology, 1993
- By-passing immunizationJournal of Molecular Biology, 1991
- Erratum: ErrataNature Biotechnology, 1991
- Structure, function and properties of antibody binding sitesJournal of Molecular Biology, 1991
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990